Related by context. All words. (Click for frequent words.) 72 Acute Decompensated Heart Failure 72 Nesiritide 72 Heart Failure Patients 70 Acute Ischemic Stroke 70 moderate hepatic impairment 70 Nebulized 70 Relapsing Multiple Sclerosis 70 Unstable Angina 70 Severe Sepsis 70 See CLINICAL PHARMACOLOGY 70 Patients Receiving 70 Combination Treatment 70 Treating Chronic 69 Oral Fingolimod 69 Appears Safe 69 Premature Infants 69 Cardiac Resynchronization 69 Heterozygous Familial Hypercholesterolemia 69 Randomized Clinical Trials 69 Improves Outcomes 69 Adjuvant Chemotherapy 69 Reduces Mortality 69 Arch Intern Med 69 Randomized Controlled Trials 69 Prospective Randomized 69 Refractory Angina 69 Rheumatoid Arthritis Patients 69 Patients Undergoing 69 Subgroup Analysis 68 Demonstrates Positive 68 Coronary Artery Bypass Graft 68 Lung Injury 68 Acute Coronary Syndromes 68 Pooled Analysis 68 Chronic Renal Failure 68 Relapsed Multiple Myeloma 68 Clinical Outcome 68 Liver Failure 68 Abciximab 68 Investigational Treatment 68 Pulmonary Arterial Hypertension 68 Resistant Hypertension 68 Acute Myocardial Infarction 68 Long Term Efficacy 68 See WARNINGS 68 Venous Thromboembolism 68 Chronic Heart Failure 68 Sleep Disturbances 67 Renal Impairment 67 Cognitive Impairment 67 Patients Treated With 67 Shows Efficacy 67 Advanced Melanoma 67 Ischemic Stroke 67 Metastatic Prostate Cancer 67 Fungal Infections 67 undergoing Percutaneous Coronary 67 Acute Heart Failure 67 Schizophrenia Treatment 67 Patient Outcomes 67 Elderly Patients 67 dual endothelin receptor antagonist 67 J Am Coll 67 Inhaled Nitric Oxide 67 Adjunctive 67 Improve Survival 67 Clinical Trial Evaluating 67 recurrent glioblastoma multiforme 67 CIMZIA TM certolizumab pegol 67 Critically Ill Patients 67 Peripheral Arterial 67 Pediatric Patients 67 Improve Outcomes 67 Diabetic Foot Ulcer 67 ANN INTERN MED 67 Pegylated Liposomal Doxorubicin 66 ACE Inhibitors 66 Randomized Clinical Trial 66 Adjuvant Treatment 66 Randomized Evaluation 66 Cardiotoxicity 66 Phase 2b Clinical Trial 66 ST Elevation Myocardial 66 Lung Cancer Survival 66 Heart Transplant Recipients 66 Meets Primary Endpoint 66 Phase III Clinical Trial 66 Non Alcoholic Fatty 66 Study Evaluating 66 Stent Placement 66 J Am Acad 66 Slow Progression 66 Rotavirus Vaccine 66 Lowers Risk 66 Bone Metastases 66 Adjunctive Therapy 66 STRIDE PD 66 myocardial infarction ventricular fibrillation 66 Treated Patients 66 Drug Prevents 66 Hepatitis C Antiviral 66 Chronic Liver Disease 66 Newly Diagnosed Multiple Myeloma 66 Acute Coronary Syndromes ACS 66 Nicotine Vaccine 66 Mg Usa 66 hepatic insufficiency 66 Therapy Reduces 66 Prophylactic Treatment 66 Chronic Myeloid Leukemia 66 Prospective Multicenter 66 Septic Shock 66 Hormone Refractory Prostate Cancer 66 Single Dose 66 Fondaparinux 66 Community Acquired Pneumonia 66 Prolongs Survival 66 Lung Cancer Patients 66 IMPACT DCM 66 Systemic Sclerosis 66 Treatment Naïve 66 atherosclerotic renal artery stenosis 66 Thromboembolism 66 Eur J 66 Acute Exacerbations 66 Knee Osteoarthritis 66 Hospital Acquired Pneumonia 66 Acute Myocardial 66 Juvenile Idiopathic Arthritis 66 ST Segment Elevation 66 Percutaneous Coronary Intervention 66 myelodysplastic myeloproliferative diseases 65 Uterine Cancer 65 Cardiovascular Outcomes 65 Circulatory Support 65 Infarct 65 Pneumococcal Vaccine 65 Plaque Psoriasis 65 Myocardial Infarction Study 65 Recurrent Breast Cancer 65 Arch Neurol 65 Renal Artery 65 Genes Predict 65 #-# Full Text 65 J Clin 65 Breast Carcinoma 65 Post Operative 65 FDA Approvals 65 Phase 2a Clinical Trial 65 Hepatotoxicity 65 Unfractionated Heparin 65 Laryngeal Cancer 65 Ischemic 65 Improves Survival 65 venous thromboembolic disease 65 Known hypersensitivity 65 Left Ventricular 65 Pivotal Trial 65 Thromboembolic 65 Tumor Response 65 Patient Enrollment 65 Hospitalized Patients 65 Clostridium difficile Infection 65 Efficacy Trial 65 Randomized Double blind 65 unstable angina pectoris 65 Renal Cell Carcinoma 65 Chronic Insomnia 65 Controlled Study 65 Left Ventricular Dysfunction 65 Meta Analysis 65 Bare Metal Stent 65 Treatment Naive Patients 65 Randomized controlled 65 Vaccine Protects Against 65 Confirmatory Phase 65 aldosterone antagonists 65 BENICAR HCT 65 Infected Patients 65 Catheter Associated 65 Randomized Controlled Trial 65 Guidelines Issued 65 Aortic Dissection 65 Proves Effective 65 Showed Significant 65 Adjuvant Therapy 65 Differential Diagnosis 65 Demonstrate Significant 65 Phase 2a Trial 65 Risk Stratification 65 Severe Asthma 65 Hormone Receptor Positive 65 Completes Patient Enrollment 65 Benign Prostatic Hyperplasia 65 Phase IIb Trial 65 Phase Ib Clinical Trial 65 First Patient Enrolled 65 Aggressive Reduction 65 Fibromyalgia Pain 65 Bipolar Depression 65 Hemodialysis Patients 65 Overactive Bladder 65 bone marrow reticulin deposition 65 Ranolazine 65 Orthostatic Hypotension 65 Clinical Trial Data 65 Stent Thrombosis 65 Kidney Transplant Patients 65 Treatment Reduces 65 Clin J 65 PEGINTRON TM 65 invasive aspergillosis 65 Drug Combo 65 ß blockers 65 Cardiovascular Events 65 Limb Ischemia 65 Ischaemic 65 Bone Fracture 65 Complicated Skin 65 Statin Therapy 65 SPRYCEL ® 65 Bioequivalence 65 Controlled Trial 65 Diabetic Kidney Disease 65 Chronic Hepatitis B 65 Myeloma Patients 64 Antipsychotic 64 Randomized Double Blind 64 Bipolar Mania 64 CHAMPION PCI 64 Surgical Treatment 64 Hepatitis C Genotype 64 Endometrial Cancer 64 Invasive Fungal Infections 64 Val HeFT 64 Aortic Stenosis 64 Dual Antiplatelet Therapy 64 MULTAQ 64 Hypotension 64 Prognostic Significance 64 Non Alcoholic Steatohepatitis 64 Acute Liver Failure 64 Pivotal Phase 64 Chronic Sinusitis 64 Prostate Cancer Patients 64 induce orthostatic hypotension 64 Hypertensive Patients 64 Reduces Pain 64 Sleep Disordered Breathing 64 Insulin Therapy 64 symptomatic hyponatremia 64 Boosts Survival 64 Castration Resistant Prostate Cancer 64 NDA Submission 64 Delayed Graft Function 64 Occlusive Disease 64 Achieves Primary Endpoint 64 NATRECOR ® 64 Carotid Endarterectomy 64 Bronchopulmonary Dysplasia 64 Acute Renal Failure 64 Randomized Study 64 Treating Heart Failure 64 Hemorrhagic Stroke 64 treatment naive genotype 64 Newly Diagnosed Breast Cancer 64 Less Invasive 64 stage IIIb IV 64 APTIVUS r 64 Antiplatelet 64 NATRECOR R 64 Relapsing Remitting Multiple Sclerosis 64 Shows Promise Against 64 Decitabine 64 Double Blind Randomized 64 receiving INTRON 64 II Clinical Trial 64 FDA APPROVES 64 Predict Risk 64 Skin Lesions 64 Coronary Artery Bypass Grafting 64 Ventricular Arrhythmias 64 Bloodstream Infections 64 VIIBRYD 64 Initiates Clinical Trial 64 unfractionated heparin UFH 64 Prevent Stroke 64 Patients Suffering 64 Treatment Experienced 64 Nonalcoholic Fatty Liver Disease 64 RECORD1 64 Exacerbation 64 HCV Protease Inhibitor 64 Advanced Prostate Cancer 64 Allergic Rhinitis 64 Therapy Improves 64 Comorbidities 64 Chronic Lung 64 Crit Care Med 64 Antiviral Therapy 64 Medication Adherence 64 Diabetic Patients 64 Previously Treated 64 Carotid Stenting 64 Coronary Angiography 64 Cholesterol Lowering Drug 64 Renal Cell Carcinoma RCC 64 Renal Cancer 64 Pivotal Phase III 64 Fecal Incontinence 64 Dose Escalation 64 Postmenopausal 64 keloid scarring 64 Clinical Evaluation 64 Chronic Hepatitis C 64 Trial Evaluating 64 Enlarged Prostate 64 Lung Cancer Trial 64 Levels Linked 64 Invasive Breast Cancer 64 Anticoagulant 64 relapsed MM 64 Glycemic Control 64 Phase III Pivotal Trial 64 Recurrent Stroke 64 Corticosteroid 64 R lenalidomide 64 Drug Shows Promise 64 Desvenlafaxine Succinate 64 Liver Injury 64 Chronic Bronchitis 64 Inhaled Corticosteroids 64 Lupus Drug 64 Subtypes 64 Demonstrated Significant 63 Refractory Hodgkin Lymphoma 63 Clinical Trial Results 63 percutaneous transluminal coronary angioplasty 63 CLINICAL PHARMACOLOGY 63 Angiographic 63 primary percutaneous coronary 63 Infarction 63 Localized Prostate Cancer 63 Immunomedics Announces 63 acutely decompensated heart 63 Main Outcome Measure 63 Coronary Artery Calcium 63 Organ Rejection 63 ACTEMRA TM 63 Completes Enrollment 63 Follicular Lymphoma 63 Mylan Receives Approval 63 ARCOXIA 63 serum phosphorous 63 CIMZIA R 63 Am J Geriatr 63 FASEB J. 63 Lifestyle Intervention 63 Aortic Valve 63 Pivotal Clinical Trial 63 Aneurysm Repair 63 Thrombolysis 63 Microalbuminuria 63 Renal Function 63 Secondary Hyperparathyroidism 63 either acutely decompensated 63 Beta Blockers 63 Clinical Trials Update 63 Reminyl galantamine 63 N Engl J 63 Breast Cancer Treatment 63 Novel Compound 63 Colorectal Cancers 63 Nephrol Dial Transplant 63 Aortic Valve Replacement 63 Placebo Controlled Trial 63 deep venous thromboses 63 J Antimicrob Chemother 63 Non Invasive Treatment 63 NSABP B 63 Serious Infections 63 Treatment Resistant 63 Depressive Symptoms 63 Treatment Shows Promise 63 Stent Implantation 63 undergoing elective percutaneous 63 Preterm Labor 63 Services #:#-#,# Abstract 63 J Natl Cancer Inst 63 LUMINATE 63 Often Misdiagnosed 63 Radical Prostatectomy 63 Recurrent Glioblastoma 63 Hyperlipidemia 63 Improve Patient Outcomes 63 Generalized Anxiety Disorder GAD 63 Clinical Outcomes 63 NICE Recommends 63 Tolvaptan 63 Cardiovascular Disease Risk 63 Inhaled Insulin 63 Breast Density 63 Multiple Myeloma Patients 63 invasive candidiasis 63 Hernia Repair 63 #mg BID [001] 63 chronic myocardial ischemia 63 Peginterferon Alfa 2a 63 Cholesterol Levels SPARCL 63 Unresectable 63 Cognitive Function 63 Advanced Colorectal Cancer 63 pioglitazone hydrochloride 63 lexidronam injection 63 Vicriviroc 63 Telithromycin 63 Malignant Glioma 63 Gastric Cancer 63 Multicenter Randomized 63 Dementia Related Psychosis 63 Mitral Regurgitation 63 Systematic Review 63 Pharmacologic 63 HCV SPRINT 63 AA Amyloidosis 63 Acute Pain 63 Epilepsy Drug 63 Patency 63 morphometric vertebral fractures 63 Bone Metabolism 63 Relapsed Refractory 63 Cerebril TM 63 Sustained Reduction 63 Vertebral Fractures 63 Myocardial Ischemia 63 Non inferiority 63 Blood Pressure Monitoring 63 Demonstrates Efficacy 63 Respiratory Distress 63 Atypical Hemolytic Uremic Syndrome 63 ARIXTRA R 63 Breast Cancer Recurrence 63 Antiplatelet Therapy 63 Endocrine Therapy 63 Intravitreal 63 mild renal insufficiency 63 Zenvia Phase III 63 Ann Oncol 63 riociguat 63 Prognostic Factors 63 Diastolic Heart Failure 63 Potent Antiviral Activity 63 Submits NDA 63 Phase 2b Trial 63 evaluating tivozanib 63 Combo Therapy 63 Postmenopausal Osteoporosis 63 Nephrol 63 Clinical Practice Guideline 63 Kidney Transplant Recipients 63 Intracranial Aneurysms 63 Long Term Outcomes 63 cytomegalovirus infection 63 number NCT# ClinicalTrials.gov 63 Intracerebral Hemorrhage 63 Mg Uk 63 HCV RESPOND 2 63 Kidney Int 63 Infusion Reactions Severe 63 Non Responders 63 Fracture Risk 63 Phase IIa Clinical Trial 63 Kidney Failure 63 #:#-#,# CrossRef Medline [002] 63 Contrast Enhanced 63 Cardiac Arrest Patients 63 Restenosis 63 Initiates Phase III 63 Ovarian Cancer Patients 63 Statin Drugs 63 Echocardiographic 63 ExTRACT TIMI 63 recurrent glioma 63 Hip Fracture 63 Curr Opin 63 MCyR 63 Vertebral Fracture 63 Phase 2b Study 63 Demonstrates Significant 63 Irbesartan 63 Percutaneous Tibial Nerve Stimulation 63 Atomoxetine 63 Chemoradiation 63 Slows Progression 63 Anticoagulation 63 Accelerated Partial Breast Irradiation 63 Dose Ranging Study 62 Treating Depression 62 hypertension congestive heart 62 Intra Arterial 62 Sapacitabine 62 Is Well Tolerated 62 CABG Surgery 62 Cardiac Resynchronization Therapy 62 Hyperkalemia 62 Node Positive 62 Betaferon R 62 Trandolapril 62 Retinal Vein Occlusion 62 Carotid Revascularization Endarterectomy vs. 62 Cardiol 62 atypical Hemolytic Uremic Syndrome 62 Migraine Pain 62 Androgen Deprivation Therapy 62 ergot derivatives 62 Total Knee Replacement 62 EURIDIS 62 receiving PEGINTRON 62 Abdominal Pain 62 Artery Disease 62 underwent resection 62 Paroxysmal Atrial Fibrillation 62 antiretroviral naïve 62 Inflammatory Diseases 62 Randomized Phase 62 Randomized Trials 62 Vertebral Compression Fractures 62 Double Blind Placebo 62 Study Shows Promise 62 Hip Fractures 62 J Clin Oncol 62 Minimally Invasive Procedure 62 Lung Function 62 Carotid Artery Stenting 62 Ann Emerg Med 62 Phase III Trial 62 alfuzosin 62 Hydroxyurea 62 Tasigna prolongs 62 Biomarker Study 62 Crit Rev 62 Hypertensive adverse reactions 62 Novel Inhibitor 62 acute mania 62 Diabetic Nephropathy 62 Pregnancy Outcomes 62 Diabetic Macular Edema 62 Colorectal Cancer Patients 62 Cutaneous T 62 Outcome Measures 62 Idiopathic Pulmonary Fibrosis 62 Disease Modifying 62 J Foot Ankle 62 MRSA Infections 62 Colorectal Adenomas 62 Arterial Disease 62 Phase IIb Clinical Trial 62 multicenter multinational 62 CT Angiography 62 Generalized Anxiety Disorder 62 Parathyroid Hormone 62 Angioedema 62 Stress Incontinence 62 DULERA 62 dyslipidemia hypertension diabetes 62 MAGE A3 ASCI 62 Stent Restenosis 62 PRoFESS 62 Schizophrenia Drug 62 Bone Marrow Transplants 62 Nonalcoholic Steatohepatitis 62 receiving XGEVA 62 Bivalirudin 62 Tyrosine Kinase Inhibitor 62 Study Showed 62 Investigational Drug 62 Gene Mutation Linked 62 Long Term Survival 62 Stress Induced 62 ARIXTRA 62 Colorectal Screening 62 Atopic Dermatitis 62 Blood Pressure Drug 62 Prostate Cancer Treatment 62 Inflammatory Markers 62 J Pediatr 62 Osteoarthritis Patients 62 Metastatic Renal Cell Carcinoma 62 Antitumor Activity 62 mcg kg REBETOL 62 Dry Powder Inhalers 62 Functional Outcomes 62 Demonstrates Sustained 62 Late Breaker 62 achieved CCyR 62 Myocardial Perfusion Imaging 62 Glatiramer Acetate 62 Total Knee Arthroplasty 62 Chronic Wounds 62 Clinically Significant 62 Drug Fails 62 Drug Eluting Stents 62 Ventricular Tachycardia 62 systolic hypertension 62 Surgical Procedures 62 Suicidality 62 Antiretroviral Therapy 62 Intervention Trial Evaluating 62 Research www. elsevier.com 62 Multicenter Study 62 Safinamide 62 TYGACIL 62 catheter occlusion 62 Monotherapy 62 Platelet Inhibition 62 Lymphocytic 62 Prognostic Value 62 By JENNIFER LEARN 62 Placebo Controlled 62 antiplatelet medications 62 Estrogen Therapy 62 ATACAND 62 Critical Limb Ischemia CLI 62 salmeterol fluticasone 62 Successfully Treated 62 Reduced Risk 62 Pivotal Study 62 Phase III Pivotal 62 Outpatient Setting 62 ELADUR ™ 62 blinded randomized placebo controlled 62 See CONTRAINDICATIONS 62 Current Controlled Trials 62 Catheter Ablation 62 Systemic Lupus Erythematosus SLE 62 Effectively Treats 62 azilsartan medoxomil 62 Intravenous Formulation 62 Antihypertensive 62 mild hepatic impairment 62 HeFH 62 antithrombotic therapy 62 Oral Calcitonin 62 drotrecogin alfa activated 62 Symptom Relief 62 STRATEGY FOR AN OPEN 62 J Clin Endocrinol Metab 62 Endovascular Repair 62 Critical Limb Ischemia 62 #mg QD [001] 62 Preterm Delivery 62 Versus Placebo 62 Minimally Invasive Treatment 62 Vascular Grafts 62 Acute Coronary Syndrome 62 aldosterone antagonist 62 Ileus 62 non splenectomized 62 Sinus Infections 62 Thrombotic 62 Brain Aneurysms 62 Test Detects 62 Postmenopausal Women 62 Induction Chemotherapy 62 Bronchiectasis 62 Raptiva r 62 Clinical Outcomes Utilizing Revascularization 62 Expanded Indication 62 #:#-#,# [002] 62 paroxetine Paxil 62 GOUT 62 Thrombus 62 REMINDER ORLive Presents 62 Valsartan 62 Eluting Stent 62 Solid Malignancies 62 Asthma COPD 62 Solid Tumors 62 orally inhaled migraine 62 HIV HCV coinfected 62 Bone Marrow Cells 62 Smoking Linked 62 Initiated Phase 62 Degarelix 62 Alteplase 62 FDA Approves Drug 62 J Shoulder Elbow 62 First Patient Treated 62 Guideline Update 62 Myocardial Infarction 62 Tigecycline 62 Shows Statistically Significant 62 Fixed Dose 62 de novo kidney transplant 62 5 Fluorouracil 62 headache abdominal pain 62 Transplant Patients 62 Fewer Side Effects 62 NCCTG N# 62 Randomized Phase III 62 HER2 Positive 62 overactive bladder syndrome 62 adalimumab Humira 62 Rilonacept 62 Cervical Dysplasia 62 Randomised 62 Physician Insights 62 COREG 62 Am J Respir 62 Valve Replacement 62 First Patient Dosed 62 somatostatin analog 62 Neoadjuvant Chemotherapy 62 Watchful Waiting 62 Renal Insufficiency 62 Partial Onset Seizures 62 Kidney Function 62 Bone Fractures 62 J Consult Clin 62 Investigational Compound 62 Obese Patients 62 FluCAM arm 62 clazosentan 62 Renal Failure 62 XYZAL R 62 Obese Teens 62 Sustained Efficacy 62 TO AVOID PREGNANCY WHILE 62 CLARITY study 62 Patients Treated 62 Autologous Stem Cell Transplantation 62 Orthop Surg 62 Capsules CII 62 Chronic Constipation 62 elevated transaminases 62 Neuroendocrine Tumors 62 Combination REOLYSIN R 62 psoriatic arthritis PsA 62 Pafuramidine 61 heparin induced thrombocytopenia 61 Initiate Phase 61 Metastatic Melanoma 61 Pain Relievers 61 Novel Oral 61 atherothrombotic events 61 Advanced Heart Failure 61 symptomatic VTE 61 Blood Pressure Reduction 61 Myoblast 61 ® lenalidomide 61 Osteoporosis Drugs 61 Significantly Improved 61 Related Mortality 61 Severely Obese 61 severe oral mucositis 61 Therapeutic Intervention 61 Tipranavir 61 Gout Drug 61 Metastatic Colorectal Cancer 61 Raloxifene Evaluation MORE 61 Abstract Accepted 61 Treatment Outcome 61 Iron Deficiency Anemia 61 interstitial brachytherapy 61 Vitrasert R 61 BZA CE 61 Seasonal Influenza Vaccine 61 Transcatheter 61 Genes Linked 61 liposome injection 61 Mycophenolate Mofetil 61 ORENCIA ® 61 Diuretic 61 Genetic Markers 61 Golimumab 61 Lupus Nephritis 61 CYT# potent vascular disrupting 61 HCV Genotype 61 #mg QD [002] 61 Telik Announces 61 Pegloticase 61 C1 Inhibitor 61 Placebo Controlled Study 61 VIVITROL ® 61 J Immunol 61 Migraine Headaches 61 Poster Presentations 61 Neonates 61 divalproex sodium 61 Survival Benefit 61 Eculizumab 61 JAK Inhibitor 61 VICTOR E1 61 intravesical infusion therapy 61 Gastrointestinal GI 61 COPD Exacerbations 61 Arch Pediatr Adolesc Med 61 Peginterferon 61 Treatment Naive HIV 61 Valvular Heart Disease 61 Venous Thrombosis 61 Significant Reduction 61 Cancer Incidence Mortality 61 Shows Promising 61 Arch Facial Plast 61 Abrupt discontinuation 61 NAVISTAR R 61 INSPIRE Trial Phase III 61 Biphasic 61 Mortality Risk 61 Free Full Text 61 Atherothrombosis 61 Stable Angina 61 eosinophilic asthma 61 Beta Blocker 61 Adenomas 61 cardiovascular hospitalizations 61 Kidney Transplants 61 Acneform rash occurred 61 RE MODEL 61 Antipsychotic Medications 61 Intervention Trial 61 Stem Cell Treatment 61 Central Retinal Vein 61 Hormone Replacement 61 Antipsychotic Drugs 61 Anemia Drug 61 Statistically Significant 61 Acute Stroke 61 postoperative atrial fibrillation 61 Phase Ib IIa 61 Ziprasidone 61 Second Pivotal Phase 61 Tumor Growth 61 Antiepileptic Drug 61 Proc Am Soc 61 Randomized Phase II 61 Urinary Incontinence 61 Antidepressants Linked 61 Hosp Epidemiol 61 Preclinical Models 61 Bucindolol 61 Paroxysmal 61 Contraindications 61 desvenlafaxine succinate 61 β blocker 61 Successfully Completes Phase 61 Naive Patients 61 Remissions 61 Reduces Risk 61 thromboprophylaxis 61 Enoxaparin 61 Pregnancy Linked 61 Prostate Cancer Vaccine 61 antiretroviral naive 61 Prostatectomy 61 tipranavir r 61 Newly Diagnosed Patients 61 Hsp# Inhibitor 61 Urinary Tract Infections 61 Initiates Enrollment 61 Migraine Headache 61 Left Atrial 61 Myelodysplastic Syndromes 61 alfa 2a 61 ALN HPN 61 dose escalation phase 61 reduce serum phosphate 61 Renal Disease 61 Balloon Angioplasty 61 PLX STROKE targeting 61 Myelodysplastic Syndrome MDS 61 Sipuleucel T 61 Lung Cancer Drug 61 nonfatal myocardial infarction MI 61 Radiation Induced 61 Emerging Therapies 61 Endarterectomy 61 glucocorticoid induced osteoporosis 61 Peptic Ulcer 61 Inflammatory Disease 61 Protease Inhibitors 61 Coronary Disease 61 Improve Diagnosis 61 Chronic HCV 61 Picoplatin Efficacy After 61 metastatic GIST 61 metastatic malignant 61 constipation OIC 61 Investigational Agent 61 Premenopausal Women 61 Ozarelix 61 Uterine Fibroids 61 Anticancer Activity 61 Advanced Ovarian Cancer 61 vapreotide acetate 61 Ischemia 61 Metabolic Efficiency 61 Dialysis Outcomes 61 randomized Phase IIb 61 dalteparin 61 Vaccine Immunology 61 TRANSDUR ™ 61 Carotid 61 Predict Response 61 Improved Survival 61 Bosutinib 61 Cardiovascular Risk 61 Cardiometabolic 61 GATTEX ™ 61 Endothelial Function 61 Vildagliptin 61 nucleoside naive 61 Pegylated Interferon 61 Mitral Valve Repair 61 Medication Errors 61 treat benign prostatic 61 #:#-# [031] 61 Cilostazol 61 Lipid Lowering 61 Transplant Rejection 61 Help Smokers Quit 61 REYATAZ ® 61 Catheterization 61 Overactive Bladder OAB 61 J Child Adolesc 61 Venous thromboembolism 61 Renal dysfunction 61 PRADAXA 61 Crit Care 61 Multicenter Phase 61 HBeAg + 61 Treat Heart Failure 61 Edge STudy 61 REALITY Trial 61 J Nutr 61 Selective Cardiac Myosin Activator 61 Certolizumab 61 Pharmacokinetic Study 61 IN PATIENTS WITH 61 mitoxantrone plus 61 prospective observational 61 Left Ventricular Hypertrophy 61 dermatologic reactions 61 Nilotinib 61 Zoledronic Acid 61 Robotic Assisted 61 Helps Relieve 61 Excessive Sweating 61 Interventional Procedures 61 Esophageal 61 Aortic Aneurysm 61 Novel Antibiotic 61 Outpatient Procedure 61 Female Stress Urinary 61 novel orally inhaled 61 Sandostatin R 61 Aflibercept 61 worsening thrombocytopenia 61 Adverse Outcomes 61 CALERIE 61 Prostate Biopsy 61 Diamyd Medical Diamyd 61 BENICAR 61 Helps Smokers Quit 61 J Virol 61 CLARITY TIMI 61 Anti Clotting Drug 61 Tuberculosis Vaccine 61 Hypercholesterolemia 61 Well Tolerated 61 velafermin 61 Hazardous Drugs 61 Testosterone Therapy 61 Helicobacter pylori eradication 61 Knee Arthritis 61 Acute Treatment 61 Candesartan 61 Implantable Cardioverter Defibrillator 61 Band 8a 61 underwent liver transplantation 61 Poorly Controlled 61 Obstet Gynecol 61 Intravascular 61 Postoperative Pain 61 Bosentan 61 Prolongs Life 61 Retreatment 61 AVAPRO 61 Muscle Function 61 Intracerebral 61 Renal Transplantation 61 Hematological Cancers 61 Advanced Solid Tumors 61 Postherpetic Neuralgia 61 Pharmacodynamics 61 Lipid Lowering Treatment 61 Anti Inflammatory Drug 61 Cypher Sirolimus